The Chinese University of Hong Kong has established a groundbreaking clinical trial centre in Nansha in collaboration with Guangzhou First People's Hospital and local authorities. This initiative marks a significant advancement in cross-border medical research within the Greater Bay Area, facilitating streamlined drug development and therapeutic testing across regional boundaries. The centre aims to leverage Hong Kong's regulatory expertise alongside mainland China's research capabilities, accelerating innovation in clinical healthcare while promoting cooperation among international medical institutions.

Summary auto-generated by AI from the original publisher's content. Editorial standards.